In people with cystic fibrosis (CF), the timing of organ transplant — lung, liver, or…
Articles by Patricia Inácio, PhD
Bioversys has entered into an exclusive collaboration and license agreement with Hackensack Meridian Health (HMH) and its…
The lungs of infants and children with cystic fibrosis (CF) show an early, overactive immune response driven by neutrophils…
Researchers at UCLA have developed a nonviral gene-editing strategy that could help pave the way for one-time treatments for people…
A new survey conducted in Germany showed that, in addition to easing symptoms and improving quality of life, Trikafta…
Persistent Pseudomonas aeruginosa infection in people with cystic fibrosis (CF) who have received treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) seems…
Almost 30% of cystic fibrosis (CF) patients who had a lung transplant in the U.S. were prescribed Trikafta…
The Cystic Fibrosis Foundation will invest up to $2.3 million for a company to develop a breath test designed to…
Treatment with Trikafta may help ease severe symptoms of anxiety and depression in children with cystic fibrosis (CF),…
A next-generation vest to help clear airway mucus in adults and children with cystic fibrosis (CF) or other lung…